ArticleThe European respiratory journal2025

Pharmacological and pre-clinical safety profile of rSIV.F/HN, a hybrid lentiviral vector for cystic fibrosis gene therapy.

Alena Moiseenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.